Ectopic growth hormone-releasing hormone secretion by a neuroendocrine tumor causing acromegaly: Long-term follow-up results

Endocrine Pathology

Volumn 20, Issue 2, 2009, Pages 127-132

  Ozbey, Neşe Colak ^a   Kapran, Yersu ^a   Bozbora, Alp ^a   Erbil, Yeşim ^a   Tascioglu, Cemil ^a   Asa, Sylvia L ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Ectopic acromegaly; GHRH; Neuroendocrine carcinoma recurrence; Octreotide

Indexed keywords

CYANOCOBALAMIN; GASTRIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; LONG ACTING DRUG; OCTREOTIDE; PENTETREOTIDE IN 111; PROLACTIN; SOMATOMEDIN; THYROXINE; VITAMIN D; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADULT; ARTHRALGIA; ARTICLE; ASPIRATION BIOPSY; CASE REPORT; CLINICAL FEATURE; CYANOCOBALAMIN DEFICIENCY; DUODENUM TUMOR; DUODENUM ULCER; FEMALE; FOLLOW UP; GASTRECTOMY; GASTRIN BLOOD LEVEL; GASTRITIS; GASTROINTESTINAL ENDOSCOPY; HEADACHE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; IRON DEFICIENCY ANEMIA; LABORATORY TEST; LOW DRUG DOSE; METASTASIS POTENTIAL; NEUROENDOCRINE TUMOR; NODULAR GOITER; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SECONDARY HYPERPARATHYROIDISM; SWEATING; VITAMIN SUPPLEMENTATION; CARCINOMA; GLUCOSE TOLERANCE TEST; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; RECURRENT DISEASE; SECRETION;

ACROMEGALY; ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; CARCINOMA, NEUROENDOCRINE; DUODENAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; GROWTH HORMONE-RELEASING HORMONE; HORMONES, ECTOPIC; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MAGNETIC RESONANCE IMAGING; OCTREOTIDE; RECURRENCE;

EID: 67651052975     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12022-009-9067-1     Document Type: Article

References (18)

1. Zatelli MC, Maffei P, Piccin D, Martini C, Rea F, Rubello D, et al. Somatostatin analogs in vitro effects in a growth hormonereleasing hormone-secreting broncial carcinoids. J Clin Endocrinol Metab 90:2104-2109, 2005. doi:10.1210/jc.2004-2156. (Pubitemid 40586246)
2. Faglia G, Arosio M, Bazzoni N. Ectopic acromegaly. Endocrinol Metab Clin North Am 21:575-595, 1992.
3. Biermasz NR, Smit JWA, Pereira AM, Frolic M, Romijin JA, Roelfsema F. Acromegaly caused by growth hormone-releasing hormone-producing tumors: long-term observational studies in three patients. Pituitary 10:237-249, 2007. doi:10.1007/s11102-007-0045-7. (Pubitemid 350055035)
4. De Jager CM, De Heide LJM, Van Den Berg G, Wolthuis A, Van Schelven WD. Acromegaly caused by a growth hormonereleasing hormone secreting carcinoid tumor of the lung: the effect of octreotide treatment. Neth J Med 65:263-266, 2007.
5. Klöppel G. Tumor biology and histopathology of neuroendocrine tumors. Best Pract Res Clin Endocrinol Metab 21:15-31, 2007. doi:10.1016/j.beem.2007.01.004. (Pubitemid 46421903)
6. Jensen RT, Rindi G, Arnold R, Loes JM, Brandi ML, Bechstein WO, et al. Well-differentiated duodenal tumor/carcinoma (excluding gastrinomas). Neuroendocrinology 84:165-172, 2006. doi:10.1159/000098008. (Pubitemid 46361050)
7. Ezzat S, Asa SL, Stefaneanu L, Whittom R, Smyth HS, Horvarth E, et al. Somatotroph hyperplasia without pituitary adenoma associated with a long standing growth hormone-releasing hormone-producing bronchial carcinoid. J Clin Endocrinol Metab 78:555-560, 1994. doi:10.1210/jc.78.3.555. (Pubitemid 24083291)
8. Nasr C, Mason A, Mayberg M, Staugaitis SM, Asa SL. Acromegaly and somatotroph hyperplasia with adenomatous transformation due to pituitary metastasis of a growth hormone-releasing hormonesecreting pulmonary endocrine carcinoma. J Clin Endocrinol Metab 91:4776-4780, 2006. doi:10.1210/jc.2006-0610. (Pubitemid 44917306)
9. Krassowski J, Zgliczynski W, Jeske W, Zgliczynski S. Comment on long-acting lanreotide inducing clinical and biochemical remission of acromegaly caused by disseminated GHRH secreting carcinoid. J Clin Endocrinol Metab 84:1760-1761, 1999, (letter). doi:10.1210/jc.84.5.1761-a.
10. Van Den Bruel A, Fevery J, Dorpe V, Hofland L, Bouillon R. Hormonal and volumetric long term control of a growth hormonereleasing hormone-producing carcinoid tumor. J Clin Endocrinol Metab 84:3162-3169, 1999. doi:10.1210/jc.84.9.3162.
11. Melmed S, Ziehl FH, Braunstein GD, Downs T, Frohman LA. Medical management of acromegaly due to ectopic production of growth hormone-releasing hormone by a carcinoid tumor. J Clin Endocrinol Metab 67:395-399, 1988.
12. Drange MR, Melmed S. Long-acting lanreotide induces clinical and biochemical remission of acromegaly caused by disseminated growth hormone-releasing hormone-secreting carcinoid. J Clin Endocrinol Metab 83:3104-3109, 1998. doi:10.1210/jc.83. 9.3104.
13. Van Hoek M, Hofland LJ, De Rijke YB, Van Nederveen FH, De Krijger RR, Van Koetsveld PM, et al. Effects of somatostatin analogs on a growth hormone-releasing hormone secreting bronchial carcinoid, in vitro and in-vivo studies. J Clin Endocrinol Metab 94:428-433 doi:10.1210/jc.2008-1712.
14. Glikson M, Gil-Ad I, Galun E, Dresner R, Zilberman S, Halperin Y, et al. Acromegaly due to ectopic growth hormone-releasing hormone secretion by a bronchial carcinoid tumour. Dynamic hormonal responses to various stimuli. Acta Endocrinol 125:366-371, 1991.
15. Bertherat J, Turpin G, Rauch C, Li JY, Eplbaum J, Sassolas G, et al. Presence of somatostatin receptors negatively coupled to adenylate cyclase-in ectopic growth hormone-releasing hormone and-subunit secreting tumors from acromegalic patients responsive to octreotide. J Clin Endocrinol Metab 79:1457-1464, 1994. doi:10.1210/jc.79.5.1457. (Pubitemid 24369866)
16. Barkan AL, Shenker Y, Grekin RJ, Vale WW. Acromegaly from ectopic growth hormone-releasing hormone secretion by a malignant carcinoid tumor. Sucessful treatment with long acting somatostatin analogue SMS 201-995. Cancer 61:221-226, 1998. doi:10.1002/1097-0142(19880115)61:2<221::AID-CNCR28 20610203>3.0.CO;2-3.
17. Arnold R, Muller H, Schade-Brittinger C, Rinke A, Klose K, Barth P, et al. Placebo-controlled, double-blind, prospective, randomized study of the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: A report from the PROMID study group. American Society of Clinical Oncology 2009 Gastrointestinal Cancer Symposium, January 15-17, 2009, Astract Book: no:121 (abstract).
18. Sano T, Asa SL, Kovacs K. Growth hormone-releasing hormoneproducing tumors: clinical, biochemical, and morphological manifestations. Endocr Rev 9:357-73, 1988. doi:10.1210/edrv-9- 3-357.